Backgrounds/Aims: This study is intended to investigate the clinicopathological features of the intraductal papillary neoplasms of the intrahepatic bile duct (IPNB), especially focused on malignant changes. Methods: From the institutional database of liver resection cases (Asan Medical Center, University of Ulsan College of Medicine), 18 patients who met the definition of IPNB were selected. They had undergone liver resection between February 2002 and October 2006; thus, the follow-up period was more than 5 years. Results: Of the 18 patients, 11 patients were male. Their mean age was 61.3±6.7 years. There were no differences between the non-malignant and malignant lesions, in the comparison of the CEA levels (5.6±2.7 vs.12.6±31.1 ng/ml, p=0.439) and the CA19-9 levels (29.2±34.7 vs.31.9±30.2 ng/ml, p=0.871). The common radiologic findings were: intraductal growing mass in 10; bile duct dilatation in 6; and saccular duct dilatation in 2. Left and right hepatectomies were performed in 15 and 3, respectively. Five patients showed benign lesions of IPNB, and 13 patients revealed malignant lesions of intraductal papillary adnocarcinoma or cholangiocarcinoma. All 4 patients with benign lesions survived for a mean period of 53 months without recurrence. In 13 patients with the malignant lesions, 1-year, 3-year, and 5-year survival rates were 100%, 84.6%, and 59.2%, respectively. Conclusions: We concluded that intrahepatic IPNB is a rare type of biliary neoplasm which includes a histological spectrum, ranging from benign disease to invasive malignancy. The long-term survival was anticipated after complete curative resection. 
INTRODUCTION
The intraductal papillary neoplasms of the bile duct (IPNB) has recently referred to certain types of papillary tumours occurring in the extrahepatic and intrahepatic bile ducts with malignant potentials. [1] [2] [3] The papillary tumours are also termed biliary papillomatosis, papillary adenomas, and papillary cholangiocarcinoma. 4 IPNB has rarely been reported in the literature. Both benign and malignant forms of biliary papillary neoplasm are classified by the WHO. 5 IPNB has also been proposed as the biliary counterpart of the intraductal papillary mucinous neoplasms of the pancreas. 6, 7 This study intended to evaluate the clinicopathological features of IPNB occurring in the intrahepatic ducts.
METHODS

Definition of the intraductal papillary neoplasms of the bile duct (IPNB)
According to Naito et al. 8 IPNB was defined as: a tumor that was localized in the liver; arose within the intrahepatic bile duct; had a major lesion that was non-infiltrative and showed an intraductal proliferation pattern;
and clinicopathologically communicated with the surrounding bile duct.
Patient selection
From our institutional database of liver resection cases,
18 patients who met the definition of intrahepatic IPNB were selected. They underwent liver resection between 
Preoperative cholangioscopic evaluation
For the percutaneous transhepatic cholangioscopy (PTCS), the initial percutaneous transhepatic biliary drainage (PTBD) was performed by using a pigtail catheter under fluoroscopic guidance. Two to 3 days after PTBD, the sinus tract was dilated. PTCS was performed 7 days after the tract dilatation. This interval was required for the sta- 
RESULTS
Demographic data and clinical characteristics
Radiological findings
All patients underwent radiological examinations, including abdomen ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP).
Endoscopic retrograde cholangio-pancreatography (ERCP) was performed in 3 patients. Preoperative PTCS evaluation was performed in 8 patients, and the malignant cells were diagnosed in 4 (50%). The common radiologic findings were: intraductal growing mass in 10, bile duct dilatation in 6, and saccular duct dilatation in 2.
Surgical procedures
Tumor 
Pathological findings
Five patients showed benign lesions of IPNB, but 13 patients revealed malignant lesions of intraductal papillary adnocarcinoma or cholangiocarcinoma (Fig. 1) . In 13 pa- 5-year survival rates were 100%, 84.6%, and 59.2%, respectively (Fig. 2) .
DISCUSSION
Intrahepatic IPNB is a rare condition, sporadically around the world. We concluded that intrahepatic IPNB is a rare type of biliary neoplasm which includes a histological spectrum ranging from benign disease to invasive malignancy. The long-term survival was anticipated after the complete curative resection. Therefore, early and accurate diagnosis is important for IPNB.
